Victoria Werth at UPenn should be on your list if she joins. https://bsky.app/profile/acr-journals.bsky.social/post/3l6x3cg26py2b
Reposted from
ACR Journals
Type I interferons (IFNs) play an important role in cutaneous lupus erythematosus and dermatomyositis skin inflammation, which could potentially be treated with IFN-targeted therapies.
Victoria Werth, MD, tackles IFNs in this summary in The Rheumatologist
www.the-rheumatologist.org/article/type...
Victoria Werth, MD, tackles IFNs in this summary in The Rheumatologist
www.the-rheumatologist.org/article/type...
Comments